• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Accessibility
  • Terms and Settings
  • Site Map
NHS Tees Valley CCG

NHS Tees Valley CCG

Tees Valley Clinical Commissioning Group

NHS Logo
  • Home
  • About Us
  • Our Work
  • Documents
  • Get Involved
  • Events
  • News
  • Contact Us
You are here: Home / Our Work / Medicines Optimisation

Medicines Optimisation

Medicines optimisation looks at the value which medicines deliver, making sure they are clinically-effective and cost-effective. It is about ensuring people get the right choice of medicines, at the right time, and are engaged in the process by their clinical team.

The goal of medicines optimisation is to help patients to:

  • Improve their outcomes;
  • Take their medicines correctly;
  • Avoid taking unnecessary medicines;
  • Reduce wastage of medicines;
  • And improve medicines safety.

Area Prescribing Committee

The County Durham and Tees Valley Area Prescribing Committee (APC) is responsible for approval of new drugs, extending the use of existing formulary drugs to new indications and for the production of the County Durham and Tees Valley Formulary which provides details of medicines approved for use in County Durham, Tees Valley and parts of North Yorkshire. Decisions around new drug requests take into consideration safety, clinical effectiveness, and cost-effectiveness relative to other treatment options for the condition under discussion, as well as the potential available budget.  Decisions will be made on fully published trial data only.

Formulary

The County Durham and Tees Valley APC formulary lists the medicines and related pharmaceutical products that are approved for use in the Tees Valley CCG NHS area.

NICE Technology Appraisals

The National Institute for Health and Social Care Excellence use evidence to produce standards and guidance for the NHS and social care to improve outcomes for people.  All CCG commissioned medicines with a positive NICE Technology Appraisal are funded, when deemed the appropriate clinical choice for patients, no later than 90 days after NICE publication.

Prescribing Guidelines

Locally developed and approved prescribing guidelines for Tees Valley CCG are published on the North of England Commissioning Support (NECS) Medicines Optimisation website.

Pharmaceutical Company Representatives

Pharmaceutical company representatives wishing to get in contact are asked to email necsu.moadmin@nhs.net

Primary Sidebar

  • Facebook
  • Twitter

Search The Site

Find events, news, documents and more.

Hartfields Public Engagement

Hartfields Public Engagement

Our Work

  • Our Work
  • Care and Treatment Reviews (CTR)
  • Continuing Healthcare
  • Contracts
  • Counter Fraud
  • Governing Body
  • Governing Body Members
  • Darlington Needs Led Neurodevelopmental Pathway
  • Information for parents and carers
  • Information for young people
  • Information for professionals
  • Specialist neurodevelopmental assessment
  • Hartlepool and Stockton’s Needs Led Neurodevelopmental Pathway
  • Information for parents and carers
  • Information for young people
  • Information for professionals
  • Specialist neurodevelopmental assessment
  • South Tees Needs Led Neurodevelopmental Pathway
  • Information for parents and carers
  • Information for young people
  • Information for professionals
  • Specialist neurodevelopmental assessment
  • Individual Funding Requests
  • Joint Committee of the Southern Collaborative of CCGs
  • Medicines Optimisation
  • Mental Health
  • Living with or at risk of Diabetes
  • NHS Oversight Framework
  • Northern CCG Joint Committee
  • Personal Health Budgets
  • Primary Care Commissioning Committee
  • Tees Valley Primary Care Networks
  • Safeguarding
  • SEND Local Offer
  • You Said, We Did
  • Host Commissioner Guidelines

© 2022 - NHS Tees Valley CCG

Manage Cookie Consent
We use cookies to optimise our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}